A Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Study of DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation

Trial Profile

A Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Study of DSP-6952 in Patients with Irritable Bowel Syndrome with Constipation

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs DSP 6952 (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Sponsors Sumitomo Dainippon Pharma
  • Most Recent Events

    • 29 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top